LENZ Insider Trading
Insider Ownership Percentage: 38.40%
Insider Buying (Last 12 Months): $15,501,073.95
Insider Selling (Last 12 Months): $0.00
LENZ Therapeutics Insider Trading History Chart
This chart shows the insider buying and selling history at LENZ Therapeutics by year and by quarter.
Skip ChartChart Data in Insider Trading History Table
LENZ Therapeutics Share Price & Price History
Current Price: $23.82
Price Change: ▲ Price Increase of +1.32 (5.87%)
As of 01/21/2025 05:00 PM ET
LENZ Therapeutics Insider Trading History
LENZ Therapeutics Institutional Trading History
Data available starting January 2016
LENZ Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies to improve vision in the United States. Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia. The company is headquartered in Del Mar, California.
Read More on LENZ Therapeutics
Today's Range
Now: $23.82
52 Week Range
Now: $23.82
Volume
142,928 shs
Average Volume
178,344 shs
Market Capitalization
$655.05 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.57
Who are the company insiders with the largest holdings of LENZ Therapeutics?
Who are the major institutional investors of LENZ Therapeutics?
Which institutional investors are selling LENZ Therapeutics stock?
In the last quarter, LENZ stock was sold by these institutional investors:
- Kelleher Financial Advisors
Which institutional investors are buying LENZ Therapeutics stock?
During the previous quarter, LENZ stock was purchased by institutional investors including:
- Harbor Capital Advisors Inc.
- SG Americas Securities LLC
Within the last year, these company insiders have bought LENZ Therapeutics stock:
- Ra Capital Management, LP (Director)
- James W Mccollum (Director)
Learn More investors buying LENZ Therapeutics stock.